Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Gilead Raday currently holds 76,150,000 shares of RedHill Biopharma Ltd. (RDHL), valued at approximately $0. This represents their equity stake as Chief Operating Officer.
Based on SEC Form 4 filings, Gilead Raday has been a net seller of RDHL stock. They have purchased $0 and sold $1.6K worth of shares.
Gilead Raday's most recent insider trade was on Apr 6, 2026, when they sold 30,780,000 shares at $0.00 per share.
Gilead Raday serves as Chief Operating Officer at RedHill Biopharma Ltd. (RDHL). They have executed 2 insider transactions totaling $1.6K over their tenure at the company.
Gilead Raday holds the position of Chief Operating Officer at RedHill Biopharma Ltd., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 1 years and currently hold a stake valued at $0.
Gilead Raday has shown a selling trading pattern, with $0 in total purchases and $1.6K in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Gilead Raday was on Apr 6, 2026, when they sold $1.6K worth of RDHL shares. This transaction involved 15,740,000 shares at N/A per share.
Gilead Raday currently owns 76,150,000 shares of RedHill Biopharma Ltd. (RDHL), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Gilead Raday's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Gilead Raday has 2 Form 4 filings on record as an insider at RedHill Biopharma Ltd..
Set alerts for Gilead Raday and 40,000+ other insiders.